Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123344402 | 12334440 | 2 | F | 201603 | 20160715 | 20160504 | 20160720 | EXP | FR-ELI_LILLY_AND_COMPANY-FR201604010032 | ELI LILLY AND CO | 76.00 | YR | F | Y | 57.90000 | KG | 20160720 | PH | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123344402 | 12334440 | 1 | PS | ZYPREXA | OLANZAPINE | 1 | Oral | UNK, UNKNOWN | Y | FR7162 | 20592 | 10 | MG | TABLET | QD | ||||
| 123344402 | 12334440 | 2 | SS | ZYPREXA | OLANZAPINE | 1 | Y | 20592 | TABLET | ||||||||||
| 123344402 | 12334440 | 3 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Unknown | 60 MG, BID | 0 | 60 | MG | CAPSULE | BID | ||||||
| 123344402 | 12334440 | 4 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Oral | 1 DF, QD | 0 | 1 | DF | CAPSULE | QD | ||||||
| 123344402 | 12334440 | 5 | C | LEXOMIL | BROMAZEPAM | 1 | Unknown | UNK, QD: 3/4 OF A TABLET | 0 | TABLET | QD | ||||||||
| 123344402 | 12334440 | 6 | C | ARIMIDEX | ANASTROZOLE | 1 | Unknown | UNK, UNKNOWN | 0 | ||||||||||
| 123344402 | 12334440 | 7 | C | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Oral | UNK, BID | U | U | 0 | BID | |||||||
| 123344402 | 12334440 | 8 | C | TRIATEC /00116401/ | ACETAMINOPHENCODEINE PHOSPHATE | 1 | Oral | UNK, BID | U | U | 0 | BID | |||||||
| 123344402 | 12334440 | 9 | C | CARDENSIEL | BISOPROLOL FUMARATE | 1 | Oral | UNK, QD | U | U | 0 | QD | |||||||
| 123344402 | 12334440 | 10 | C | ALDACTONE | SPIRONOLACTONE | 1 | Oral | UNK, QD | U | U | 0 | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123344402 | 12334440 | 1 | Depression |
| 123344402 | 12334440 | 2 | Generalised anxiety disorder |
| 123344402 | 12334440 | 3 | Depression |
| 123344402 | 12334440 | 4 | Generalised anxiety disorder |
| 123344402 | 12334440 | 5 | Product used for unknown indication |
| 123344402 | 12334440 | 6 | Breast cancer |
| 123344402 | 12334440 | 7 | Product used for unknown indication |
| 123344402 | 12334440 | 8 | Product used for unknown indication |
| 123344402 | 12334440 | 9 | Product used for unknown indication |
| 123344402 | 12334440 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123344402 | 12334440 | HO |
| 123344402 | 12334440 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123344402 | 12334440 | Cardiac failure | |
| 123344402 | 12334440 | Myocardial infarction | |
| 123344402 | 12334440 | Off label use | |
| 123344402 | 12334440 | Pulmonary oedema |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123344402 | 12334440 | 1 | 20160325 | 20160422 | 0 |